Researchers assessed data from short-term studies with open-label extensions among adults and adolescents with bipolar depression to assess the impact of lurasidone on treatment-emergent mania.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Study findings do not support the use of vitamin D3 supplementation to prevent depression in adults.
Now more than ever, clinicians need to be in check with their emotions as the COVID-19 pandemic can cause feelings of sadness, loneliness, and depression.
Simple coping behaviors may protect against anxiety and depressive symptoms during the COVID-19 pandemic and lockdown.
Study finds screening methods for teenage girls and adult women are generally accurate for the diagnosis of generalized anxiety disorder.
More than 40% of nurses on the front lines during the pandemic may be experiencing burnout.
In children with ASD, sameness behaviors and anxiety may be indicative of future behavioral trajectories.
Researchers explored provider screening practices in primary care, women’s health, and well-child clinics to determine if barriers exist in meeting postpartum depression screening guidelines.
